Editors-in-Chief Drs. Alex A. Adjei and Emily Stone will talk with members during a Meet-the-Editor session on Monday afternoon. Read more
An expert panel from the US National Cancer Institute’s Early Detection Research Network provided insights into the current state of the art as well as barriers to use. Read more
However, lead author Dr. Matthew Smeltzer said the new data also show clinicians value biomarker testing more in late-stage disease compared to early-stage disease. Read more
During the session, experts will not only review the updates, they will also discuss how they approached the process and the guidelines’ limitations. Read more
Former IASLC CEO Dr. Paul A. Bunn, Jr., says lung cancer is a global challenge and the unique multinational and multi-specialty nature of the IASLC has helped to build a global response. Read more
The WCLC 2024 program includes several opportunities to browse posters and see the latest in thoracic oncology research. Read more
The session will also include late-breaking data from HARMONi-2, NeoCOAST-2, and TROPION-Lung01 as well as an address from IASLC President Dr. Paul Van Schil. Read more
While women remain a minority in thoracic oncology, Drs. Narjust Florez and Linda Martin say change is happening. The duo will co-chair a special session designed to address issues faced by women in the field. Read more
Dr. Caicun Zhou discusses his plans for WCLC 2024 as well as his goals for his time as IASLC President. Read more
In a Q&A with ILCN, patient advocate Isaac Joseph discusses the importance of patient advocacy in resource-limited settings. Read more